Table 2.
Type | Radionuclide | Source of sEVs / EMVs; size; isolation method | Radiolabelling condition | Purification | RLY | In vitro stability; assessed by | In vivo imaging | Ref. |
---|---|---|---|---|---|---|---|---|
Surface radiolabelling | 125I-biotin | B16-BL6 mouse melanoma cells; 70 ± 3 nm; UC | 30 min; 37°C; 10 µg |
Not reported | ~ 80%* | > 95% serum stability at 4 h; UF | û | 78 |
As above | û | 79 | ||||||
Na131I + iodo-bead method |
Various | 30 min; RT; not reported |
UF = Nanosep 100k Omega | >80% for 4T1 EVs* | ca. 80% serum stability at 24 h*; iTLC | √ | 80 | |
99mTc-tricarbonyl | Human red blood cells; 188 ± 11 nm; UC + UF + SEC | 30 min; RT; 0.6 mL |
Zeba spin desalting column | 38.8 ± 6.2% | No data given | √ | 81 | |
99mTc-tricarbonyl | HEK 293T human embryonic kidney cells; ~77 nm; not reported | 1 h; 37°C; 20 µg |
None used | > 98% | 96% saline stability at 24 h; TLC | √ | 82 | |
99mTc (+ SnCl2) |
Goat milk; 122 ± 1 nm; UC and SEC | 30 min; 37°C; 75 µg |
Exosome spin column | 37 ± 9% | 95% PBS stability at 48 h; iTLC | √ | 83 | |
111In-DTPA | B16-F10 mouse melanoma cells; 132 ± 6 nm; UC | 30 min; 37°C; 1x1011 sEVs |
SEC = Sepharose CL-2B | 19.2 ± 4.5% | 86.8 ± 3.1% PBS stability, and 80.4 ± 1.6% serum stability at 24 h; iTLC | √ | 84 | |
Intraluminal radiolabelling | 111In-oxinate | PC3 human prostate cancer cells; 140 ± 59 nm; UC | 20 min; RT; 2.5-3.7 mg/mL |
SEC = P6 column | 81% | No data given | û | 85 |
MCF-7 human breast cancer cells; 130 ± 57 nm; UC | 67% | |||||||
111In-oxinate | HEK 293 human embryonic kidney cells; 106 ± 14 nm; UF + UC | 30 min; RT; 1x109 sEVs/mL |
UF = Amicon ultra 100 kDa | > 98% | > 92% serum stability at 24 h; iTLC | √ | 86 | |
111In-tropolone | B16-F10 mouse melanoma cells; 132 ± 6 nm; UC | 20 min; 37°C; 1x1011 sEVs |
SEC = Sepharose CL-2B | 4.7 ± 0.4% | 43.4 ± 10.1% PBS stability, and 14.2 ± 2.8% serum stability at 24 h; SEC | √ | 84 | |
99mTc-HMPAO | Raw 264.7 mouse macrophages; 218 ± 8 nm; serial extrusion | 1 h; RT; 100 µg |
SEC = PD-10, MW3000 spin column | > 93% | ~ 90% serum stability at 5 h; iTLC | √ | 87 | |
99mTc (+ SnCl2) |
Rat red blood cells; 201 ± 16 nm; serial extrusion | 20 min; 37°C; 100 µg |
UC (only if RLY < 95% on iTLC) | 100% | 93 ± 3% serum stability at 24 h; iTLC | √ | 88 |